Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience

被引：0
|
作者：
Kim, Hong Joo [1 ]
Kim, Nam Hee [1 ]
机构：
[1] Sungkyunkwan Univ, Dept Internal Med, Kangbuk Samsung Hosp, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
721
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [21] Clinical utility of entecavir for chronic hepatitis B in Chinese patients
    Wang, Jiyao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 13 - 24
  • [22] Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: A single center experience
    Sun, J
    Wang, ZH
    Ma, SW
    Zeng, GB
    Zhou, ZY
    Luo, KX
    Hou, JL
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (03) : 391 - 398
  • [23] Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
    Nam, Joon Yeul
    Lee, Jeong-Hoon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (04) : 311 - 313
  • [24] Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study
    Batirel, Ayse
    Guclu, Ertugrul
    Arslan, Ferhat
    Kocak, Funda
    Karabay, Oguz
    Ozer, Serdar
    Turanli, Munevver
    Mert, Ali
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 28 : 153 - 159
  • [25] Efficacy and safety of long term entecavir in Chronic Hepatitis B NUC naive patients in real life
    Ridruejo, Ezequiel
    Marciano, Sebastian
    Galdame, Omar A.
    Virginia Reggiardo, Maria
    Munoz, Alberto
    Adrover, Raul
    Cocozzella, Daniel R.
    Fernandez, Nora C.
    Estepo, Claudio R.
    Mendizabal, Manuel
    Romero, Gustavo
    Levi, Diana
    Schroder, Teresa
    Paz, Silvia
    Fainboim, Hugo
    Mando, Oscar G.
    Gadano, Adrian
    Silva, Marcelo O.
    HEPATOLOGY, 2013, 58 : 636A - 636A
  • [26] Real-Life Effectiveness of DAA in Chronic Hepatitis C - the Swiss Experience
    Moschouri, Eleni
    Salemme, Gloria
    Baserga, Adriana
    Cerny, Andreas
    Deibel, Ansgar
    Mullhaupt, Beat
    Meier, Marie-Anne
    Bernsmeier, Christine
    Ongaro, Marie
    Negro, Francesco
    Grosjean, Marielle
    Clerc, Olivier
    Kunzler-Heule, Patrizia
    Semela, David
    Hobi, Gabriel
    Stickel, Felix
    Mathieu, Adeline
    Mdawar-Bailly, Elise
    Faouzi, Mohamed
    Moradpour, Darius
    Fraga, Montserrat
    SWISS MEDICAL WEEKLY, 2022, 152 : 9S - 9S
  • [27] Efficacy and Safety of Entecavir Treatment of Chronic Hepatitis B Patients in Real-world clinical Practice
    Tanwandee, Tawesak
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Chotiyaputta, Watcharasak
    Nimanong, Supot
    HEPATOLOGY, 2013, 58 : 672A - 672A
  • [28] Long-term entecavir therapy of chronic hepatitis B in real-life setting-Importance of quantitative HBsAg level
    Ray, Gautam
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (03) : 652 - 659
  • [29] Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection
    Nguyen, L. H.
    Hoang, J.
    Nguyen, N. H.
    Vu, V. D.
    Wang, C.
    Trinh, H. N.
    Li, J.
    Zhang, J. Q.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (04) : 390 - 399
  • [30] Emergence of hepatitis B virus gene mutation related to entecavir-resistance in chronic hepatitis B patients participated in the phase 2 clinical studies of entecavir in Japan
    Kobashi, Haruhiko
    Fujioka, Shin-ichi
    Kumada, Hiromitsu
    Yokosuka, Osamu
    Hayashi, Norio
    Suzuki, Kazuyuki
    Okanoue, Takeshi
    Sata, Michio
    Tsubouchi, Hirohito
    Sato, Chifumi
    Kiyosawa, Kendo
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Sakaguchi, Kosaku
    Shiratori, Yasushi
    Ishikawa, Hiroki
    Seriu, Taku
    Omata, Masao
    HEPATOLOGY, 2007, 46 (04) : 666A - 666A
12345